Natus Medical Denmark ApS — Credit Rating and Financial Key Figures
CVR number: 25384687
Hørskætten 9, Klovtofte 2630 Taastrup
tel: 45755555
Income statement (mDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | 435.87 | 382.15 | 327.94 | 268.18 | 175.36 |
| Costs of manufacturing | - 206.06 | - 104.47 | -64.12 | ||
| Gross profit | 435.87 | 382.15 | 121.88 | 163.71 | 111.24 |
| Costs of management | -48.85 | -50.95 | -60.37 | ||
| Costs of distribution | -82.23 | -80.09 | -58.41 | ||
| Other operating expenses | - 160.29 | - 196.46 | -92.70 | ||
| EBIT | -91.00 | - 138.70 | - 169.50 | - 163.78 | - 100.24 |
| Other financial income | 2.57 | 0.92 | 36.25 | ||
| Other financial expenses | -80.75 | -66.66 | -17.87 | ||
| Net income from associates (fin.) | 32.11 | ||||
| Pre-tax profit | -82.75 | -62.92 | - 247.68 | - 197.41 | -81.86 |
| Income taxes | 53.45 | -41.97 | -0.08 | ||
| Net earnings | -82.75 | -62.92 | - 194.23 | - 239.38 | -81.93 |
Assets (mDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Development expenditure | 85.19 | 47.26 | 61.54 | ||
| Intangible rights | 13.71 | ||||
| Intangible assets total | 98.90 | 47.26 | 61.54 | ||
| Buildings | 7.49 | 7.42 | 6.67 | ||
| Tangible assets total | 7.49 | 7.42 | 6.67 | ||
| Holdings in group member companies | 47.84 | 47.84 | 33.26 | ||
| Other non-current investments | 273.98 | 205.19 | |||
| Investments total | 273.98 | 205.19 | 47.84 | 47.84 | 33.26 |
| Deferred tax assets | 41.89 | ||||
| Long term receivables total | 41.89 | ||||
| Semifinished products | 0.50 | 0.32 | 1.75 | ||
| Raw materials and consumables | 1.16 | 1.37 | 1.58 | ||
| Finished products/goods | 31.68 | 2.39 | 4.30 | ||
| Inventories total | 33.34 | 4.08 | 7.63 | ||
| Current trade debtors | 8.61 | 6.29 | 5.85 | ||
| Current amounts owed by group member comp. | 85.13 | 5.36 | 17.31 | ||
| Prepayments and accrued income | 0.23 | 0.01 | 1.63 | ||
| Current other receivables | 236.83 | 333.12 | 2.21 | 4.55 | 2.14 |
| Short term receivables total | 236.83 | 333.12 | 96.18 | 16.21 | 26.94 |
| Cash and bank deposits | 2.45 | 0.23 | 0.11 | ||
| Cash and cash equivalents | 2.45 | 0.23 | 0.11 | ||
| Balance sheet total (assets) | 510.81 | 538.31 | 328.08 | 123.05 | 136.16 |
Equity and liabilities (mDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Share capital | - 163.55 | - 226.47 | 24.00 | 24.00 | 24.00 |
| Other reserves | 66.45 | 36.86 | 48.00 | ||
| Retained earnings | 82.75 | 62.92 | - 316.92 | - 481.56 | - 176.51 |
| Profit of the financial year | -82.75 | -62.92 | - 194.23 | - 239.38 | -81.93 |
| Shareholders equity total | - 163.55 | - 226.47 | - 420.70 | - 660.08 | - 186.44 |
| Provisions | - 510.81 | - 538.31 | 2.74 | 0.91 | 0.88 |
| Non-current other liabilities | 61.81 | 35.06 | 2.74 | ||
| Non-current deferred tax liabilities | 5.80 | 5.77 | 5.65 | ||
| Non-current liabilities total | 61.81 | 35.06 | 8.55 | 5.77 | 5.65 |
| Current trade creditors | 7.99 | 4.78 | 7.43 | ||
| Current owed to group member | 691.73 | 754.07 | 286.29 | ||
| Short-term deferred tax liabilities | 5.40 | 0.20 | 0.14 | ||
| Other non-interest bearing current liabilities | 612.55 | 729.72 | 27.38 | 17.10 | 21.74 |
| Accruals and deferred income | 7.73 | 0.29 | 0.47 | ||
| Current liabilities total | 612.55 | 729.72 | 740.24 | 776.45 | 316.06 |
| Balance sheet total (liabilities) | 330.83 | 123.05 | 136.16 |
Try the full version of our system for free
Create your own estimates for any company
Valuation analysis
See instructions
... and more!
No registration needed.